Navigation Links
VirtualScopics Schedules Fourth Quarter 2008 Earnings Announcement
Date:2/12/2009

gs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limited to, statements regarding the backlog and new customer awards in 2008 and/or statements preceded by, followed by or that include the words "believes," "could," "expects," "anticipates," "estimates," "intends," "plans," "projects," "seeks," or similar expressions. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Many of these risks and uncertainties are discussed in the Company's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at www.sec.gov. These include without limitation: the risk of cancellation or delay of customer contracts or specifically as it relates to awards of contracts currently under negotiation, the risk that they may not get signed. Other risks include the company's dependence on its largest customers and risks of contract performance. All forward-looking statements speak only as of the date of this pre
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nasdaq Grants VirtualScopics Request for Continued Listing
2. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
3. LifeCell Corporation Schedules Third Quarter 2007 Financial Results Conference Call; October 25, 2007 at 10:00 A.M. Eastern
4. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
5. WorldHeart Schedules Teleconference
6. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
9. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
10. LifeCell Corporation Revises Full Year 2007 Preliminary Results and Schedules Fourth Quarter 2007 Financial Results Conference Call; February 27, 2008 at 10:00 a.m. Eastern
11. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Filippov (MIPT and Russian Quantum Center at Skolkovo) ... Republic, and the Institute of Physics in Bratislava, ... entanglement of particles passing through an amplifier and, ... Details are provided in an article published in ... preprint). , Quantum entangled particles are considered to ...
(Date:7/23/2014)... 23, 2014 Shimadzu Scientific Instruments ... acid analysis system developed jointly with Ajinomoto Co. ... can analyze 38 amino acids in nine minutes, ... achieves high-speed analysis utilizing a fast application-specific column ... accurate analytical results even under conditions with difficult ...
(Date:7/23/2014)... Jolla, CA (PRWEB) July 23, 2014 ... stem cell therapy in the US aimed at improving ... announced their newest clinical study for Parkinson’s disease. ... efficacy of stem cell therapy are paramount when providing ... This clinical study makes stem cell therapy accessible to ...
(Date:7/23/2014)... 23, 2014 regulated information -- UCB today announced ... pipeline with positive topline results from the latest ... was designed to evaluate the efficacy and safety ... without titration) compared to placebo, as adjunctive treatment ... not fully controlled despite treatment with one or ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
... Therapeutics (NYSE Amex: CXM ) today reported that the Company has received a letter ... the Company,s exchange listing compliance. , , , ... , , ... , , In the ...
... ... come when sorghum, sugar cane and other crops are considered , ... (PRWEB) July 7, 2010 -- Banning the agricultural ... to University of Chicago economist Don L. Coursey, Ph.D . , , ,Dr. Coursey ...
... July 7 DATATRAK International, Inc. (OTCQX: DATA), a ... the clinical trials industry, today announced that it privately placed ... per share with certain members of its Board of ... the private placement are restricted securities and are subject to ...
Cached Biology Technology:Cardium Regains Listing Compliance With NYSE Amex 2Cardium Regains Listing Compliance With NYSE Amex 3Cardium Regains Listing Compliance With NYSE Amex 4Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 2Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 3DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 3
(Date:7/24/2014)... at Albert Einstein College of Medicine of ... J. Fox Foundation for Parkinson,s Research to translate a ... This drug discovery project will test chemical compounds on ... a drug that acts on an underlying cause of ... help many people manage their symptoms, we are eager ...
(Date:7/24/2014)... vision specialist at The University of Texas Health Science ... a grant to help Harris County residents whose vision ... , Even with corrective lenses, many people with low ... a variety of low vision devices, such as telescopes, ... loss. , Iyer is using the three-year, $164,645 SightFirst ...
(Date:7/24/2014)... have similar counterparts in humans, affect the connections between ... into the hippocampus, an area of the brain that ... creation of memories. The results of the study have ... Brain function depends on the active communication between nerve ... woven together into a dense network where they constantly ...
Breaking Biology News(10 mins):Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3UTHealth Dr. Bhavani Iyer awarded low vision grant 2A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4
... popular forage and turf grass called tall fescue covers a vast ... to be larger than Virginia and Maryland combined -- and a ... there is more to fescue than meets the eye. Results ... Journal of Applied Ecology , show that a symbiotic fungus living ...
... fertilized egg cell. Following numerous cell divisions, it then ... tissues. The largely unexplained process whereby the cells simply ... is an astonishing phenomenon. Scientists from the Center for ... and the University of Wageningen, in cooperation with colleagues ...
... From cutting-edge photovoltaic power generation systems to substrates ... materials are playing an expanding role in the world,s ... Ceramic Society (ACerS) today launched a major peer-reviewed journal ... of Applied Glass Science ( IJAGS ). ...
Cached Biology News:Study: Grass, fungus combination affects ecology 2How plants put down roots 2Ceramic society launches new glass science and applications journal 2
... The enzyme glycerol 3-phosphate dehydrogenase ... phosphate (DHAP) and glycerol 3-phosphate, with ... increases significantly during differentiation of progenitor ... activity of this enzyme has been ...
... is a K-12 strain ideally suited as ... high transformation efficiency, blue/white screening capability (with ... result in high yields of excellent quality ... is potentially useful as a stringent host ...
... are intended for laboratory research use only. ... neutral buffered formalin and embedded in paraffin. ... by certified pathologists. Tissue cores were ... into a new recipient paraffin block, in ...
... rabbit blood (New Zealand White or Californian ... is refrigerated within 6 hours of collection, ... -20ºC. The serum is then thawed in ... in-house protocol, filtered through a 0.22 micron ...
Biology Products: